your provider may adjust based on tolerance and clinical response
Alternative Options: Brand-Name Through Insurance: Work with insurance to access Wegovy or Ozempic Local Compounding Pharmacy: Some local compounding pharmacies compound semaglutide with a prescription from your doctor Clinical Trials: Research studies may provide access Manufacturer Programs: Patient assistance programs for brand-name medications Regulatory Changes to Watch: Compounded medication availability can change based on: FDA shortage list updates (if semaglutide is removed from shortage list, compounding may become restricted) State law changes affecting telemedicine or compounding New federal regulations on compounding DEA or FDA enforcement actions Legitimate providers will notify patients of any regulatory changes affecting their ability to provide compounded semaglutide
Zalipsky S, Qazen M, Walker JA, Mullah N, Quinn YP, Huang SK
Common prescription options include Estrace, Premarin, and vaginal estrogen tablets like Vagifem or Imvexxy
MAUD-T2D trial: Patients with T2D and markers of more severe AUD, comparing newer GLP-1 RAs to FDA-approved medications for AUD (MAUD: acamprosate, disulfiram, or naltrexone)